{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T15:32:50Z","timestamp":1768923170253,"version":"3.49.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TCRM"],"DOI":"10.2147\/tcrm.s9165","type":"journal-article","created":{"date-parts":[[2010,9,10]],"date-time":"2010-09-10T04:18:36Z","timestamp":1284092316000},"page":"383","source":"Crossref","is-referenced-by-count":2,"title":["Molecular mechanisms and treatment strategies for Dupuytren’s disease"],"prefix":"10.2147","author":[{"given":"Bing Siang","family":"Gan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2010,8]]},"container-title":["Therapeutics and Clinical Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=7519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:08:31Z","timestamp":1477865311000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/molecular-mechanisms-and-treatment-strategies-for-dupuytrenrsquos-dise-peer-reviewed-article-TCRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/tcrm.s9165","relation":{},"ISSN":["1178-203X"],"issn-type":[{"value":"1178-203X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}